Anida Pharma Overview

  • Founded
  • 2013
  • Status
  • Private
  • Latest Deal Type
  • Angel
  • (Cancelled)
  • Investors
  • 1

Anida Pharma General Information


Operator of a biopharmaceutical company intended to develop targeted therapeutics in the fields of vision, hearing and cognition. The company develops a pipeline of treatments that targets sensory organ dysfunction and with an initial focus on high unmet medical needs in pediatric patients, enabling the medical industry to prevent and restore neuro-sensory dysfunction.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Primary Industry
Drug Discovery
Other Industries
Primary Office
  • 155 Brookline Street
  • Suite 005
  • Cambridge, MA 02139
  • United States
+1 (617) 000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Anida Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Angel (individual) 15-Oct-2015 Cancelled Pre-Clinical Trials
2. Grant 27-Sep-2013 Completed Pre-Clinical Trials
1. Angel (individual) Completed Pre-Clinical Trials
To view Anida Pharma’s complete valuation and funding history, request access »

Anida Pharma Executive Team (1)

Name Title Board Seat Contact Info
Per Gjorstrup MD Founder, President & Chief Executive Officer
To view Anida Pharma’s complete executive team members history, request access »

Anida Pharma Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Michael J. Fox Foundation Limited Partner 000 0000 000000 0
To view Anida Pharma’s complete investors history, request access »